Incidence and risk factors of discontinuation of tofacitinib and biologic disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis: A population-based cohort study

Journal

Clinical Rheumatology

Journal Volume

43

Journal Issue

12

Start Page

3625-3637

ISSN

0770-3198

1434-9949

Date Issued

2024-10-11

Author(s)

Po-Cheng Shih

Po-Cheng Hung

Jui-Ning Hsu

Chieh-Chun Yang

Hsin-Hua Chen

DOI

URI

Publisher

Springer Science and Business Media LLC

Type

journal-article